PCP
WVE icon

Proficio Capital Partners’s Wave Life Sciences WVE Stock Holding History

Proficio Capital Partners’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-11
Closed – – 2097
2019
Q1 		$0 Buy
+11
New +$446 ﹤0.01% 1782

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Proficio Capital Partners's WVE Position: Q2 2019 in Review

Proficio Capital Partners sold out of Wave Life Sciences (WVE) in Q2 2019, closing a stake of 11 shares.

Proficio Capital Partners first reported a position in WVE in Q1 2019 and held it in 1 quarter. The position peaked at $0 in Q1 2019. 100 funds tracked by Wall St. Rank hold WVE as of Q2 2019.

  • Proficio Capital Partners reported no remaining Wave Life Sciences position as of Q2 2019 after selling out during the quarter.
  • Proficio Capital Partners sold 11 Wave Life Sciences shares in Q2 2019.
  • Proficio Capital Partners first reported a position in Wave Life Sciences in Q1 2019 and held it in 1 quarter.
  • Proficio Capital Partners's Wave Life Sciences position peaked at $0 in Q1 2019.
  • 100 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2019.

Based on Proficio Capital Partners's 13F filing for Q2 2019, filed 13 Aug 2019.